<SEC-DOCUMENT>0001104659-25-055610-index.html : 20250602
<SEC-HEADER>0001104659-25-055610.hdr.sgml : 20250602
<ACCEPTANCE-DATETIME>20250602191011
ACCESSION NUMBER:		0001104659-25-055610
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250531
FILED AS OF DATE:		20250602
DATE AS OF CHANGE:		20250602

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			MACK DAVID J.
		CENTRAL INDEX KEY:			0001694466
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38410
		FILM NUMBER:		251016701

	MAIL ADDRESS:	
		STREET 1:		7550 WISCONSIN AVENUE
		STREET 2:		9TH FLOOR
		CITY:			BETHESDA
		STATE:			MD
		ZIP:			20814

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BioXcel Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001720893
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				821386754
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		555 LONG WHARF DRIVE
		CITY:			NEW HAVEN
		STATE:			CT
		ZIP:			06511
		BUSINESS PHONE:		203-643-8060

	MAIL ADDRESS:	
		STREET 1:		555 LONG WHARF DRIVE
		CITY:			NEW HAVEN
		STATE:			CT
		ZIP:			06511
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>tm2516926-1_4seq1.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: tm2516926-1_4seq1.html

Document 1 - RAW XML: tm2516926-1_4seq1.xml

</DOCUMENT>
</SEC-DOCUMENT>